Imperial College London

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1907-07-08

Employees: 5K

Market Cap: -

Website: http://www.imperial.ac.uk

Clinical Trials

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

Phase 1

Completed

Conditions: HIV

Interventions: Other: Sodium chloride BP
Biological: GTU®-MultiHIV B Clade Vaccine

First Posted Date: 2015-05-29

Last Posted Date: 2016-11-10

Lead Sponsor: Imperial College London

Target Recruit Count: 30

Registration Number: NCT02457689

Locations: 🇬🇧
Imperial College London, Greater London, United Kingdom

Effectiveness of Ripple Mapping in Atrial Tachycardia Ablation

Not Applicable

Completed

Conditions: Atrial Tachycardia

Interventions: Device: Ripple Mapping guided AT ablation
Device: Local activation Time Mapping AT Ablation

First Posted Date: 2015-05-22

Last Posted Date: 2019-07-25

Lead Sponsor: Imperial College London

Target Recruit Count: 105

Registration Number: NCT02451995

Locations: 🇬🇧
Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom

Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication

Not Applicable

Completed

Conditions: Intermittent Claudication
Peripheral Vascular Disease

Interventions: Device: Neuromuscular Electrical Stimulation

First Posted Date: 2015-05-06

Last Posted Date: 2020-09-29

Lead Sponsor: Imperial College London

Target Recruit Count: 21

Registration Number: NCT02436200

Locations: 🇬🇧
Imperial College London - Charing Cross Hospital, London, Hammersmith, United Kingdom

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs

Not Applicable

Completed

Conditions: Pulmonary Arteriovenous Malformations
Hereditary Hemorrhagic Telangiectasia

Interventions: Other: Cardiopulmonary exercise test
Procedure: Blood test

First Posted Date: 2015-05-06

Last Posted Date: 2023-09-28

Lead Sponsor: Imperial College London

Target Recruit Count: 39

Registration Number: NCT02436213

Locations: 🇬🇧
Hammersmith Hospital, Du Cane Rd, London, United Kingdom

Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC

Not Applicable

Completed

Conditions: Intermittent Claudication
Peripheral Vascular Disease
Lower Limb Arterial Disease

Interventions: Device: Revitive IX

First Posted Date: 2015-04-29

Last Posted Date: 2020-10-08

Lead Sponsor: Imperial College London

Target Recruit Count: 42

Registration Number: NCT02429310

Locations: 🇬🇧
Imperial College London - Charing Cross Hospital, London, Hammersmith, United Kingdom

European Celecoxib Trial in Primary Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Other: Placebo
Drug: Celecoxib

First Posted Date: 2015-04-29

Last Posted Date: 2020-06-23

Lead Sponsor: Imperial College London

Target Recruit Count: 2639

Registration Number: NCT02429427

Transperineal Ultrasound to Assess the Progress of Labour

Completed

Conditions: Vaginismus
Placenta Praevia

First Posted Date: 2015-04-29

Last Posted Date: 2024-10-07

Lead Sponsor: Imperial College London

Target Recruit Count: 584

Registration Number: NCT02430038

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Longitudinal Phenotyping of Bariatric Surgery Patients

Completed

Conditions: Obesity
Diabetes Mellitus, Type 2

Interventions: Procedure: Laparoscopic Roux-en-Y Gastric Bypass
Procedure: Laparoscopic Sleeve Gastrectomy

First Posted Date: 2015-04-20

Last Posted Date: 2020-11-06

Lead Sponsor: Imperial College London

Target Recruit Count: 158

Registration Number: NCT02421055

Locations: 🇬🇧
Imperial Weight Centre, London, United Kingdom

Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Standard opened loop pump
Device: Bi-hormonal closed loop pump
Device: Insulin closed loop

First Posted Date: 2015-03-24

Last Posted Date: 2019-11-01

Lead Sponsor: Imperial College London

Target Recruit Count: 24

Registration Number: NCT02397265

Locations: 🇬🇧
Imperial College, London, United Kingdom

Preventing Recurrent Gestational Diabetes With Metformin

Phase 4

Conditions: Gestational Diabetes Mellitus

Interventions: Drug: placebo
Drug: Metformin

First Posted Date: 2015-03-20

Last Posted Date: 2019-08-13

Lead Sponsor: Imperial College London

Target Recruit Count: 112

Registration Number: NCT02394158

Locations: 🇬🇧
London North West Healthcare Trust, London, United Kingdom
🇬🇧
Imperial College NHS Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy